These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9748418)

  • 1. Isolation and characterization of the viscous, high-molecular-mass microbial carbohydrate fraction from faeces of healthy subjects and patients with Crohn's disease and the consequences for a therapeutic approach.
    Ruseler-van Embden JG; Van Lieshout LM; Binnema DJ; Hazenberg MP
    Clin Sci (Lond); 1998 Oct; 95(4):425-33. PubMed ID: 9748418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a soluble bacterial carbohydrate fraction on the viscosity of intestinal contents in healthy subjects and patients with Crohn's disease.
    Hazenberg MP; Pennock-Schröder AM; Wensinck F; Van de Merwe JP
    Eur J Clin Invest; 1989 Feb; 19(1):61-4. PubMed ID: 2499463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
    Boege F; Fischbach W
    Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn's disease: an observational study.
    Walton C; Montoya MP; Fowler DP; Turner C; Jia W; Whitehead RN; Griffiths L; Waring RH; Ramsden DB; Cole JA; Cauchi M; Bessant C; Naylor SJ; Hunter JO
    Eur J Clin Nutr; 2016 Sep; 70(9):1052-6. PubMed ID: 27167669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition.
    Shiga H; Kajiura T; Shinozaki J; Takagi S; Kinouchi Y; Takahashi S; Negoro K; Endo K; Kakuta Y; Suzuki M; Shimosegawa T
    Dig Liver Dis; 2012 Sep; 44(9):736-42. PubMed ID: 22622202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives.
    Van de Merwe JP; Schröder AM; Wensinck F; Hazenberg MP
    Scand J Gastroenterol; 1988 Nov; 23(9):1125-31. PubMed ID: 3247591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased proteolysis and leucine aminopeptidase activity in faeces of patients with Crohn's disease.
    Ruseler-van Embden JG; van Lieshout LM
    Digestion; 1988; 40(1):33-40. PubMed ID: 3069527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers.
    Devani M; Cugno M; Vecchi M; Ferrero S; Di Berardino F; Avesani EC; de Franchis R; Colman RW
    Am J Gastroenterol; 2002 Aug; 97(8):2026-32. PubMed ID: 12190172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocortin-present perforating and lipocortin-absent nonperforating Crohn's disease.
    Sakanoue Y; Horai T; Okamoto T; Hatada T; Shoji Y; Fujita S; Kusunoki M; Utsunomiya J
    Am J Surg; 1992 Oct; 164(4):341-4. PubMed ID: 1415941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deglycosylation of alpha 1-proteinase inhibitor is impaired in the faeces of patients with active inflammatory bowel disease (Crohn's disease).
    Mizon C; el Yamani J; Colombel JF; Maes P; Balduyck M; Laine A; Cortot A; Tartar A; Mizon J
    Clin Sci (Lond); 1991 May; 80(5):517-23. PubMed ID: 1851694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy.
    Hudson MJ; Hill MJ; Elliott PR; Berghouse LM; Burnham WR; Lennard-Jones JE
    J Med Microbiol; 1984 Dec; 18(3):335-45. PubMed ID: 6334160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
    Sandborn WJ; Tremaine WJ; Lawson GM
    Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased faecal glycosidases in patients with Crohn's disease.
    Ruseler-van Embden JG; van Lieshout LM
    Digestion; 1987; 37(1):43-50. PubMed ID: 3609504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease.
    Klasen IS; Melief MJ; van Halteren AG; Schouten WR; van Blankenstein M; Hoke G; de Visser H; Hooijkaas H; Hazenberg MP
    Clin Immunol Immunopathol; 1994 Jun; 71(3):303-8. PubMed ID: 7515336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease.
    Noth R; Stüber E; Häsler R; Nikolaus S; Kühbacher T; Hampe J; Bewig B; Schreiber S; Arlt A
    J Crohns Colitis; 2012 May; 6(4):464-9. PubMed ID: 22398062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased gastric and intestinal permeability in patients with Crohn's disease.
    Wyatt J; Oberhuber G; Pongratz S; Püspök A; Moser G; Novacek G; Lochs H; Vogelsang H
    Am J Gastroenterol; 1997 Oct; 92(10):1891-6. PubMed ID: 9382060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the capability of a gelling complex made of tara gum and the exopolysaccharides produced by the microorganism Streptococcus thermophilus ST10 to prospectively restore the gut physiological barrier: a pilot study.
    Del Piano M; Balzarini M; Carmagnola S; Pagliarulo M; Tari R; Nicola S; Deidda F; Pane M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S56-61. PubMed ID: 25291130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease.
    Breslin NP; Nash C; Hilsden RJ; Hershfield NB; Price LM; Meddings JB; Sutherland LR
    Am J Gastroenterol; 2001 Oct; 96(10):2934-8. PubMed ID: 11693329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.
    De Cruz P; Kang S; Wagner J; Buckley M; Sim WH; Prideaux L; Lockett T; McSweeney C; Morrison M; Kirkwood CD; Kamm MA
    J Gastroenterol Hepatol; 2015 Feb; 30(2):268-78. PubMed ID: 25087692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.